Those Needing Medical Intervention Clinical obesity (BMI 30 or 27 with comorbidities), type 2 diabetes requiring management, or other metabolic conditions needing pharmaceutical treatment should not be addressed primarily through supplements marketed with misleading GLP-1 claims
Drug interactions and contraindications While DSIP has not been extensively studied for drug interactions, its mechanism of action suggests several important precautions
5- GSK (GlaxoSmithKline)_ *London, United Kingdom* A_Therapies:_ vaccines (Shingrix), HIV, respiratory, oncology
Beau's Note Korean inner beauty is worth taking seriously, but not uncritically
In 2025, VMAIL reported that the American Optometric Association (AOA) had released a clinical report by their evidence-based optometry committee warning of some serious ocular complications associated with GLP-1 receptor agonists, including exacerbation of age-related macular degeneration, progression of diabetic retinopathy and the rare but serious onset of NAION
The potential use of plant natural products and plant extracts with antioxidant properties for the prevention/treatment of neurodegenerative diseases: in vitro, in vivo and clinical trials
